Evaluation of Patients With Blood Disorders
Evaluation of Hematologic Patients - Training Protocol
Sponsor: National Institutes of Health Clinical Center (CC)
Listed as NCT00001715, this observational or N/A phase trial focuses on Hematologic Disease and remains completed. Sponsored by National Institutes of Health Clinical Center (CC), it has been updated 27 times since 1998, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Study Description(click to expand)The Hematology Service provides hematology consultations for patients at the Clinical Center and participates in the training of hematology fellows. Patients with a broad range of hematologic disorders must be available in order for the senior staff of the Service to maintain clinical expertise and to provide the breadth of experience necessary for the fellowship program. The purpose of this protocol is to meet these needs by allowing the Hematology Service to see patients with a spectrum of hematologic diseases not studied on existing research protocols at the NIH. These patients will be evaluated over the course of several outpatient visits and returned to the care of their referring physicians.
The Hematology Service provides hematology consultations for patients at the Clinical Center and participates in the training of hematology fellows. Patients with a broad range of hematologic disorders must be available in order for the senior staff of the Service to maintain clinical expertise and to provide the breadth of experience necessary for the fellowship program. The purpose of this protocol is to meet these needs by allowing the Hematology Service to see patients with a spectrum of hematologic diseases not studied on existing research protocols at the NIH. These patients will be evaluated over the course of several outpatient visits and returned to the care of their referring physicians.
Status Flow
Change History
27 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jan 2020 — Jan 2021 [monthly]
Completed
▶ Show 22 earlier versions
-
Dec 2019 — Jan 2020 [monthly]
Completed
-
Nov 2019 — Dec 2019 [monthly]
Completed
-
Oct 2019 — Nov 2019 [monthly]
Completed
-
Sep 2019 — Oct 2019 [monthly]
Completed
-
Aug 2019 — Sep 2019 [monthly]
Completed
-
Jul 2019 — Aug 2019 [monthly]
Completed
-
Jun 2019 — Jul 2019 [monthly]
Completed
-
May 2019 — Jun 2019 [monthly]
Completed
-
Apr 2019 — May 2019 [monthly]
Completed
-
Mar 2019 — Apr 2019 [monthly]
Completed
-
Feb 2019 — Mar 2019 [monthly]
Completed
-
Jan 2019 — Feb 2019 [monthly]
Completed
-
Dec 2018 — Jan 2019 [monthly]
Completed
-
Nov 2018 — Dec 2018 [monthly]
Completed
-
Oct 2018 — Nov 2018 [monthly]
Completed
-
Sep 2018 — Oct 2018 [monthly]
Completed
-
Aug 2018 — Sep 2018 [monthly]
Completed
-
Jul 2018 — Aug 2018 [monthly]
Completed
-
Jun 2018 — Jul 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Apr 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institutes of Health Clinical Center (CC)
For direct contact, visit the study record on ClinicalTrials.gov .